Artelo Biosciences Inc (ARTL) — Financial Flexibility Index
Artelo Biosciences Inc (ARTL) has a Financial Flexibility Index of -1.04x as of December 2025. Free cash flow of $-4.25 Million (operating CF $-4.25 Million minus capex $0.00) represents -1% of total liabilities ($4.07 Million). Also explore Artelo Biosciences Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Artelo Biosciences Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Artelo Biosciences Inc across 11 annual periods. Check ARTL capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Artelo Biosciences Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Artelo Biosciences Inc. For the full company profile including market capitalisation, see ARTL market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.09x | $-8.52 Million | $-8.52 Million | $4.07 Million | ▲ +53.9% |
| 2024 | -4.54x | $-8.35 Million | $-8.35 Million | $1.84 Million | ▲ +28.7% |
| 2023 | -6.36x | $-8.21 Million | $-8.21 Million | $1.29 Million | ▲ +18.9% |
| 2022 | -7.84x | $-8.01 Million | $-8.01 Million | $1.02 Million | ▲ +24.3% |
| 2021 | -10.36x | $-6.14 Million | $-6.14 Million | $593.00K | ▼ -82.7% |
| 2020 | -5.67x | $-2.85 Million | $-4.35 Million | $502.18K | ▼ -348.1% |
| 2019 | -1.26x | $-1.29 Million | $-2.79 Million | $1.02 Million | ▲ +58.2% |
| 2018 | -3.02x | $-1.61 Million | $-1.61 Million | $531.97K | ▲ +58.8% |
| 2017 | -7.34x | $-215.98K | $-216.82K | $29.44K | ▼ -623.1% |
| 2016 | -1.01x | $-17.64K | $-18.49K | $17.39K | ▲ +86.1% |
| 2015 | -7.28x | $-12.66K | $-13.50K | $1.74K | — |